Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Zikang Li
Xingtai People's Hospital - Department of Hepatobiliary Surgery
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
61
TOTAL CITATIONS
0
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
Anti-HBV Therapy in Hepatocellular Carcinoma May Affect the Symptoms of SARS-CoV-2 Infection
Number of pages: 19
Posted: 22 May 2023
Yan Xu
,
Fang Sun
,
Chaohui Xiao
,
Guanglin Lei
,
Jitao Wang
,
Mingguang Wang
, Zikang Li,
Zhaohai Wang
and
Rong Liu
Government of the People's Republic of China - Department of Pancreatic Hepatobiliary Surgery, Government of the People's Republic of China - Department of Pancreatic Hepatobiliary Surgery, Government of the People's Republic of China - Department of Pancreatic Hepatobiliary Surgery, Government of the People's Republic of China - Department of Hepatobiliary Surgery, Government of the People's Republic of China - Department of Hepatobiliary Surgery, Xingtai People's Hospital - Department of Hepatobiliary Surgery, Xingtai People's Hospital - Department of Hepatobiliary Surgery, Government of the People's Republic of China - Department of Pancreatic Hepatobiliary Surgery and Government of the People's Republic of China - Department of Pancreatic Hepatobiliary Surgery
Downloads
61
(951,658)
View PDF
Download
Abstract:
SARS-CoV-2, hepatocellular carcinoma, anti-HBV therapy, IL-2, T cell, prognosis
Feedback
